David Spackman

Diagnostics Market Access & Commercial Strategy Consultant – UK
Find him/her on :

Specialization
Diagnostics Commercialisation, Market Access, NHS Adoption Strategy
David brings 20+ years of experience in healthcare and life sciences, with a strong focus on the strategy, commercialisation and large-scale adoption of innovative diagnostic technologies. He combines commercial leadership with deep knowledge of clinical pathways and healthcare system complexity, helping companies translate scientific and technological advances into clinically impactful and commercially viable solutions across the UK healthcare landscape.
Key expertise areas
Diagnostics commercial strategy
Market access and reimbursement
NICE guidance
NHS tender strategy and execution
UK genomics implementation
Commercial excellence
Stakeholder engagement
Multifunctional team leadership
Clinical pathway integration
Notable engagements
Markets
United Kingdom, with deep experience across the NHS ecosystem and engagement with senior stakeholders including clinicians, NHS leaders, government representatives, charities and industry partners.
Our team
Hervé Pouzoullic

Founder & CEO
Lee Creaser

Senior Commercial Execution Consultant
Miguel Viribay

Commercial Intelligence & Market Analysis Consultant – Spain
Alex Yoboue

International Business Development Consultant
Rita Boukamel

Senior Healthcare Executive & Strategic Growth Consultant
Yannick Delpu, Ph.D.

Business Development & Go-to-Market Consultant
Eric Michel

Medical Devices P&L Growth & Execution Excellence Consultant
Frieda Gerdes

Business Development & Market Access Consultant – Germany
Simone Guenther

Strategic Commercial Leader – Single-Cell & Multiomics
Sabina Nidzworska

Regulatory Affairs, Quality & IVDR/MDR Consultant
Gerald Wiegand

Senior Biopharmaceutical & Life Sciences Executive
Franck Lescure

Advisor Fundraising & Development Strategy / Life Sciences